KMT2A-AF4 was the only fusion gene documented in BM-MSCs from KMT2A-AF4-positive B-ALL cases, suggesting that this specific mutation could arise in pre-hematopoietic precursors [59]. Here, KMT2A is linked to precursor B-cell acute lymphoblastic leukemia.